Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × Melanoma × Clear all

Melanoma

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06472661 2025-11-20

Mel 70

Phase EARLY_PHASE1 Recruiting

11 enrolled

Dermatologic

Melanoma

NCT06216938 2025-04-10

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

Phase EARLY_PHASE1 Recruiting

25 enrolled

Dermatologic

Melanoma

NCT04541108 2024-04-18

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Phase EARLY_PHASE1 Recruiting

15 enrolled

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

Clinical Trials

Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Mel 70

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies